Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone tissue and cancer].

J F Rossi1

  • 1Laboratoire des Technologies Nouvelles, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France.

Pathologie-Biologie
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Bone remodeling, crucial for skeletal health, involves bone formation and resorption. Cancer disrupts this balance, leading to abnormal bone changes, particularly in B-cell malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro Activation of B-CLL Cells.

Leukemia & lymphoma·2016
Same author

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.

Leukemia·2010
Same author

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.

Oncogene·2009
Same author

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.

Bone marrow transplantation·2006
Same author

Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma.

Oncology·2005
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
Same journal

[Diagnostic performance of graphical anomalies in the detection of large platelets and platelet clumps].

Pathologie-biologie·2015
Same journal

Association analysis of APOA5 rs662799 and rs3135506 polymorphisms with obesity in Moroccan patients.

Pathologie-biologie·2015
See all related articles

Area of Science:

  • Bone biology and cellular micro-environments
  • Cytokine signaling in skeletal homeostasis
  • Cancer-induced skeletal pathologies

Context:

  • Bone remodeling is a dynamic process regulated by osteoblasts and osteoclasts.
  • Local and systemic factors, including cytokines and bone matrix components, modulate bone remodeling.
  • Cancer significantly alters bone remodeling, often causing uncoupled bone formation and resorption.

Purpose:

  • To review the mechanisms of bone remodeling and its dysregulation in cancer.
  • To highlight the role of cytokines and tumor micro-environments in cancer-associated bone disease.
  • To differentiate bone remodeling abnormalities in myeloma versus other B-cell malignancies.

Summary:

  • Bone remodeling, a balance between osteoblastic bone formation and osteoclastic bone resorption, is modulated by cellular micro-environments, local factors, and hormones.

Related Experiment Videos

  • Cancer disrupts this balance, leading to decreased bone formation and increased resorption, often an uncoupled phenomenon.
  • In B-cell malignancies, abnormal bone remodeling is an early event, with myeloma exhibiting distinct osteoclast differentiation compared to other B-cell cancers, driven by synergistic factors from tumor cells and the micro-environment.

    • Impact:

    • Understanding cancer-induced bone remodeling is critical for managing skeletal complications.
    • Identifying specific factors involved in abnormal bone remodeling can lead to targeted therapies.
    • Distinguishing bone pathology in different B-cell malignancies aids in personalized treatment strategies.